Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus Monotherapy

Alemtuzumab was used as an induction agent in 205 renal transplant recipients undergoing 207 living donor renal transplants. All donor kidneys were recovered laparoscopically. Postoperatively, patients were treated with tacrolimus monotherapy, and immunosuppression was weaned when possible. Forty-se...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tan, H. P., Kaczorowski, D. J., Basu, A., Unruh, M., McCauley, J., Wu, C., Donaldson, J., Dvorchik, I., Kayler, L., Marcos, A., Randhawa, P., Smetanka, C., Starzl, T. E., Shapiro, R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2006
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3154761/
https://ncbi.nlm.nih.gov/pubmed/16889606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2006.01495.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky